BioMaxima S.A.
Manufacturer and distributor of in-vitro diagnostics for clinical microbiology.
BMX | WAR
Overview
Corporate Details
- ISIN(s):
- PLBIOMX00015
- LEI:
- 2594007GAALFMXP4YB89
- Country:
- Poland
- Address:
- Lublin Vetterów 5, 20-277 Lublin
- Website:
- https://www.biomaxima.com/
- Sector:
- Manufacturing
Description
BioMaxima S.A. is a manufacturer specializing in in-vitro diagnostics. The company's primary activities include the development and production of a wide range of products for laboratory diagnostics, with a focus on clinical microbiology. Key product categories include microbiological media, various diagnostic reagents, and specialized laboratory equipment. In addition to its manufacturing operations, BioMaxima also serves as a distributor for products from other global diagnostics firms. The company is actively involved in product innovation, including the development of Minimum Inhibitory Concentration (MIC) tests for antibiotic susceptibility testing.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-28 17:42 |
Skrócony skonsolidowany raport kwartalny
|
Polish | 951.6 KB | ||
| 2025-11-21 14:50 |
Podpisanie znaczącej umowy - Content (PL)
|
Polish | 815 bytes | ||
| 2025-11-21 14:12 |
Podpisanie znaczącej umowy - Content (PL)
|
Polish | 951 bytes | ||
| 2025-09-30 17:15 |
Raport Biegłego z przeglądu skróconego spawozdania jednostkowego
|
Polish | 345.0 KB | ||
| 2025-09-30 17:15 |
Raport Biegłego z przeglądu sprawozdania skonsolidowanego
|
Polish | 348.4 KB | ||
| 2025-09-30 17:15 |
Sprawozdanie Zarządu za I półrocze 2025
|
Polish | 727.0 KB | ||
| 2025-09-30 17:15 |
Skonsolidowane sprawozdanie półroczne ze skróconymsprawozdaniem finansowym
|
Polish | 1.5 MB | ||
| 2025-09-30 17:15 |
List Prezesa Zarządu do akcjonariuszy
|
Polish | 255.8 KB | ||
| 2025-09-26 08:18 |
Dostawa analizatora - Content (PL)
|
Polish | 663 bytes | ||
| 2025-08-27 12:45 |
Informacja o otrzymaniu dofinansowania w kwocie 1.097.835,17 zł na rozbudowę of…
|
Polish | 1.7 KB | ||
| 2025-08-08 20:29 |
Zawiadomienie 19 MAR
|
Polish | 8.0 KB | ||
| 2025-08-08 20:29 |
Zawiadomienie od osoby zobowiązanej - Content (PL)
|
Polish | 213 bytes | ||
| 2025-07-15 12:07 |
Podpisanie znaczącej umowy - Content (PL)
|
Polish | 581 bytes | ||
| 2025-06-27 14:00 |
Podpisanie znaczącej umowy - Content (PL)
|
Polish | 776 bytes | ||
| 2025-06-25 13:05 |
zal01_Wykaz_akcjonariuszy.pdf
|
Polish | 127.8 KB |
Automate Your Workflow. Get a real-time feed of all BioMaxima S.A. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for BioMaxima S.A.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for BioMaxima S.A. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
